Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Molecules and Cells

• Publication date

  2005-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.MOLCEL.2005.02.030PMID 15808507
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multiubiquitin chain receptors define a layer of substrate selectivity in the ubiquitin-proteasome system.

  2004cited by this paper
• Amyotrophic lateral sclerosis with neuronal intranuclear protein inclusions

  2004cited by this paper
• Molecular clearance of ataxin‐3 is regulated by a mammalian E4

  2004cited by this paper
• Proteolysis-independent regulation of the transcription factor Met4 by a single Lys 48-linked ubiquitin chain

  2004cited by this paper
• Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death

  2004cited by this paper
• A Mutant Ataxin-3 Putative-Cleavage Fragment in Brains of Machado-Joseph Disease Patients and Transgenic Mice Is Cytotoxic above a Critical Concentration

  2004cited by this paper
• Poly-ubiquitin Binding by the Polyglutamine Disease Protein Ataxin-3 Links Its Normal Function to Protein Surveillance Pathways*

  2004cited by this paper
• Ataxin-3 Interactions with Rad23 and Valosin-Containing Protein and Its Associations with Ubiquitin Chains and the Proteasome Are Consistent with a Role in Ubiquitin-Mediated Proteolysis

  2003cited by this paper
• Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates

  2003cited by this paper
• Protein degradation and protection against misfolded or damaged proteins

  2003cited by this paper
• Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course.

  2003cited by this paper
• The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity.

  2003influential reference
• Fly models of Huntington's disease.

  2003cited by this paper
• Human neurodegenerative disease modeling using Drosophila.

  2003cited by this paper
• Elucidation of ataxin-3 and ataxin-7 function by integrative bioinformatics.

  2003cited by this paper
• From fruit fly to bedside: translating lessons from Drosophila models of neurodegenerative disease

  2003cited by this paper
• Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1.

  2003cited by this paper
• An automated method for high-throughput protein purification applied to a comparison of His-tag and GST-tag affinity chromatography

  2003cited by this paper
• Recruitment of nonexpanded polyglutamine proteins to intranuclear aggregates in neuronal intranuclear hyaline inclusion disease

  2003cited by this paper
• Molecular Pathways of Neurodegeneration in Parkinson's Disease

  2003cited by this paper
• Polyglutamines placed into context.

  2003cited by this paper
• Dying for a cause: invertebrate genetics takes on human neurodegeneration

  2003cited by this paper
• Toxic Proteins in Neurodegenerative Disease

  2002cited by this paper
• Recruitment of a 19S Proteasome Subcomplex to an Activated Promoter

  2002cited by this paper
• Chaperoning brain degeneration

  2002influential reference
• Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila.

  2002cited by this paper
• Identification of ter94, Drosophila VCP, as a modulator of polyglutamine-induced neurodegeneration

  2002cited by this paper
• Targeted expression of dominant negative proteasome mutants in drosophila melanogaster

  2002cited by this paper
• Mouse and fly models of neurodegeneration.

  2002cited by this paper
• Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease

  2001cited by this paper
• A ubiquitin-interacting motif conserved in components of the proteasomal and lysosomal protein degradation systems.

  2001cited by this paper
• Ubiquitination-dependent mechanisms regulate synaptic growth and function

  2001cited by this paper
• Non-expanded polyglutamine proteins in intranuclear inclusions of hereditary ataxias – triple-labeling immunofluorescence study

  2001cited by this paper
• Recruitment of Nonexpanded Polyglutamine Proteins to Intranuclear Aggregates in Neuronal Intranuclear Hyaline Inclusion Disease

  2001cited by this paper
• Regulation of Transcriptional Activation Domain Function by Ubiquitin

  2001cited by this paper
• Tauopathy in Drosophila: Neurodegeneration Without Neurofibrillary Tangles

  2001cited by this paper
• Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila

  2001cited by this paper
• Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo.

  2001cited by this paper
• Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila.

  2000cited by this paper
• Molecular genetics: Unmasking polyglutamine triggers in neurodegenerative disease

  2000influential reference
• A Drosophila model of Parkinson's disease

  2000influential reference
• Ataxin-3 is translocated into the nucleus for the formation of intranuclear inclusions in normal and Machado-Joseph disease brains.

  2000cited by this paper
• Identification of genes that modify ataxin-1-induced neurodegeneration

  2000cited by this paper
• Ataxin-3, the MJD1 gene product, interacts with the two human homologs of yeast DNA repair protein RAD23, HHR23A and HHR23B.

  2000cited by this paper
• Glutamine repeats and neurodegeneration.

  2000cited by this paper
• Recognition of the polyubiquitin proteolytic signal

  2000cited by this paper
• Genetic analysis of the role of the drosophila fat facets gene in the ubiquitin pathway.

  1999cited by this paper
• The dominant temperature-sensitive lethal DTS7 of Drosophila melanogaster encodes an altered 20S proteasome beta-type subunit.

  1999cited by this paper
• Dominant-negative mutation in the beta2 and beta6 proteasome subunit genes affect alternative cell fate decisions in the Drosophila sense organ lineage.

  1999cited by this paper
• Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons.

  1998cited by this paper
• Recruitment and the Role of Nuclear Localization in Polyglutamine-mediated Aggregation

  1998cited by this paper
• Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila.

  1998influential reference
• The ubiquitin system.

  1998cited by this paper
• Homozygosity for Machado-Joseph disease gene enhances phenotypic severity.

  1996cited by this paper
• Machado-Joseph Disease: Correlation between the Clinical Features, the CAG Repeat Length and Homozygosity for the Mutation

  1996cited by this paper
• Ubiquitin-dependent protein degradation.

  1996cited by this paper
• Expanded polyglutamine in the Machado–Joseph disease protein induces cell death in vitro and in vivo

  1996cited by this paper
• Identification of an essential gene, l(3)73Ai, with a dominant temperature-sensitive lethal allele, encoding a Drosophila proteasome subunit.

  1993cited by this paper
• No-bridge of Drosophila melanogaster: portrait of a structural brain mutant of the central complex.

  1992cited by this paper

• Pathogenesis of polyglutamine diseases: Piecing together a complex molecular puzzle.

  2026cites this paper
• Restoration of Shal/KV4 proteostasis and motor function in a Drosophila model of spinocerebellar ataxia type 19/22

  2025cites this paper
• Molecular hallmarks of neurodegeneration in polyglutamine spinocerebellar ataxias

  2025cites this paper
• GABAergic neuronal dysfunction underlies tremor in spinocerebellar ataxia 3

  2025cites this paper
• An acyclic nucleic acid-modified siRNA targeting CAG expansions for polyglutamine disease treatment

  2025cites this paper
• Wings of Discovery: Using Drosophila to Decode Hereditary Spastic Paraplegia and Ataxias

  2025cites this paper
• ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3

  2024cites this paper
• Comparative analysis of BAG1 and BAG2: Insights into their structures, functions and implications in disease pathogenesis.

  2024cites this paper
• Modeling neurodegenerative and neurodevelopmental disorders in the Drosophila mushroom body

  2024cites this paper
• Drosophila as a Model for Human Disease: Insights into Rare and Ultra-Rare Diseases

  2024cites this paper
• The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases

  2024cites this paper
• Insight into the early pathogenesis and therapeutic strategies of spinocerebellar ataxia type 3/machado-joseph disease from mouse models.

  2024cites this paper
• Ubiquitin-binding site 1 of pathogenic ataxin-3 regulates its toxicity in Drosophila models of Spinocerebellar Ataxia Type 3

  2023influential citation
• Drosophila melanogaster as a model to study autophagy in neurodegenerative diseases induced by proteinopathies

  2023influential citation
• A survey of protein interactions and posttranslational modifications that influence the polyglutamine diseases

  2022influential citation
• Lignin-carbohydrate complexes suppress SCA3 neurodegeneration via upregulating proteasomal activities.

  2022cites this paper
• CBP-Mediated Acetylation of Importin α Mediates Calcium-Dependent Nucleocytoplasmic Transport of Selective Proteins in Drosophila Neurons

  2022cites this paper
• A fine balance between Prpf19 and Exoc7 in achieving degradation of aggregated protein and suppression of cell death in spinocerebellar ataxia type 3

  2021cites this paper
• Tyramine synthesis, vesicular packaging, and the SNARE complex function coordinately in astrocytes to regulate Drosophila alcohol sedation

  2021cites this paper
• n-Butylidenephthalide Modulates Autophagy to Ameliorate Neuropathological Progress of Spinocerebellar Ataxia Type 3 through mTOR Pathway

  2021cites this paper
• Mutant Ataxin-3–Containing Aggregates (MATAGGs) in Spinocerebellar Ataxia Type 3: Dynamics of the Disorder

  2021cites this paper
• Toxicity of pathogenic ataxin-2 in Drosophila shows dependence on a pure CAG repeat sequence

  2021cites this paper
• The impact of proteostasis dysfunction secondary to environmental and genetic causes on neurodegenerative diseases progression and potential therapeutic intervention

  2020cites this paper
• Degron capability of the hydrophobic C‐terminus of the polyglutamine disease protein, ataxin‐3

  2020cites this paper
• Examination of genetic and pharmacological tools to study the proteasomal deubiquitinating enzyme ubiquitin‐specific protease 14 in the nervous system

  2020cites this paper
• Ubiquitin-interacting motifs of ataxin-3 regulate its polyglutamine toxicity through Hsc70-4-dependent aggregation

  2020cites this paper
• Ubiquitin Substrates Dramatically Increase Ataxin3 Deubiquitinating Activity: Allosteric crosstalk connects three distinct sites

  2020cites this paper
• Deficiency in classical nonhomologous end-joining–mediated repair of transcribed genes is linked to SCA3 pathogenesis

  2020cites this paper
• Praja1 ubiquitin ligase facilitates degradation of polyglutamine proteins and suppresses polyglutamine-mediated toxicity

  2020cites this paper
• Drosophila Glia: Models for Human Neurodevelopmental and Neurodegenerative Disorders

  2020cites this paper
• Pathogenesis of SCA3 and implications for other polyglutamine diseases.

  2020cites this paper
• Polyglutamine spinocerebellar ataxias: emerging therapeutic targets

  2020cites this paper
• The inherited ataxias

  2020cites this paper
• From quality control to neurodegeneration : regulation of autophagy and the DNA damage response by ubiquitin-modifying enzymes

  2020influential citation
• Post-translational Modifications: A Mystery to Unravel Huntington’s Disease Prognosis

  2019cites this paper
• Targeting Ubiquitin Proteasome Pathway with Traditional Chinese Medicine for Treatment of Spinocerebellar Ataxia Type 3.

  2019cites this paper
• FipoQ/FBXO33, a Cullin‐1‐based ubiquitin ligase complex component modulates ubiquitination and solubility of polyglutamine disease protein

  2019cites this paper
• Inhalational Aesthetic Sevoflurane Exacerbates Eye Phenotype of SCA3 Transgenic Drosophila Model

  2019cites this paper
• The Machado–Joseph disease deubiquitylase ataxin‐3 interacts with LC3C/GABARAP and promotes autophagy

  2019cites this paper
• Fully automated leg tracking of Drosophila neurodegeneration models reveals distinct conserved movement signatures

  2019influential citation
• Differential toxicity of ataxin-3 isoforms in Drosophila models of Spinocerebellar Ataxia Type 3.

  2019cites this paper
• Polyglutamine repeat proteins disrupt actin structure in Drosophila photoreceptors

  2018cites this paper
• Repeat Expansion Disease Models.

  2018cites this paper
• Machado–Joseph disease/spinocerebellar ataxia type 3: lessons from disease pathogenesis and clues into therapy

  2018cites this paper
• Automated leg tracking reveals distinct conserved gait and tremor signatures in Drosophila models of Parkinson’s Disease and Spinocerebellar ataxia 3

  2018cites this paper
• A peptidylic inhibitor for neutralizing expanded CAG RNA-induced nucleolar stress in polyglutamine diseases

  2018influential citation
• The identification of cell non-autonomous roles of astrocytes in neurodegeneration

  2018cites this paper
• AQAMAN, a bisamidine-based inhibitor of toxic protein inclusions in neurons, ameliorates cytotoxicity in polyglutamine disease models

  2018cites this paper
• Physiological and pathophysiological characteristics of ataxin-3 isoforms

  2018cites this paper
• Glial expression of disease-associated poly-glutamine proteins impairs the blood–brain barrier in Drosophila

  2018cites this paper
• Inhibition of NF-κB in astrocytes is sufficient to delay neurodegeneration induced by proteotoxicity in neurons

  2018cites this paper
• Experimental and Clinical Strategies for Treating Spinocerebellar Ataxia Type 3.

  2018cites this paper
• Roles of Post-translational Modifications in Spinocerebellar Ataxias

  2018cites this paper
• Toxicity and aggregation of the polyglutamine disease protein, ataxin-3 is regulated by its binding to VCP/p97 in Drosophila melanogaster.

  2018cites this paper
• Animal Models of Machado-Joseph Disease.

  2018cites this paper
• The CAG-polyglutamine repeat diseases: a clinical, molecular, genetic, and pathophysiologic nosology.

  2018cites this paper
• Manipulations of Protective Post-Translational Modifications of Ataxin-3 as a Possible Treatment of SCA 3

  2018cites this paper
• The identification of cell non-autonomous roles of astrocytes in neurodegeneration

  2018cites this paper
• Planar cell polarity gene Fuz triggers apoptosis in neurodegenerative disease models

  2018cites this paper
• Interaction between the AAA+ ATPase p97 and its cofactor ataxin3 in health and disease: Nucleotide-induced conformational changes regulate cofactor binding

  2017cites this paper
• Modelling in miniature : Using Drosophila melanogaster to study human neurodegeneration

  2017cites this paper
• Mitophagy in neurodegenerative diseases

  2017cites this paper
• Drosophila melanogaster As a Model Organism to Study RNA Toxicity of Repeat Expansion-Associated Neurodegenerative and Neuromuscular Diseases

  2017influential citation
• Investigation of the multi-domain aggregation mechanism of ataxin-3

  2017cites this paper
• Molecular Chaperone Hsp70 and Its Constitutively Active Form Hsc70 Play an Indispensable Role During Eye Development of Drosophila melanogaster

  2017cites this paper
• Toward Understanding the Polyglutamine Disorder Spinocerebellar Ataxia Type 3 Using Mouse Models of Disease

  2017cites this paper
• Post-translational Modifications and Protein Quality Control in Motor Neuron and Polyglutamine Diseases

  2017cites this paper
• Proteolytic Cleavage of Polyglutamine Disease-Causing Proteins: Revisiting the Toxic Fragment Hypothesis.

  2017cites this paper
• Comparison of spinocerebellar ataxia type 3 mouse models identifies early gain-of-function, cell-autonomous transcriptional changes in oligodendrocytes

  2017cites this paper
• The Ubiquitination, Disaggregation and Proteasomal Degradation Machineries in Polyglutamine Disease

  2017influential citation
• Ataxin‐3 consolidates the MDC1‐dependent DNA double‐strand break response by counteracting the SUMO‐targeted ubiquitin ligase RNF4

  2017cites this paper
• Polyglutamine spinocerebellar ataxias — from genes to potential treatments

  2017cites this paper
• Expanded and Wild-type Ataxin-3 Modify the Redox Status of SH-SY5Y Cells Overexpressing α-Synuclein

  2017cites this paper
• Sedimentation Velocity Analysis with Fluorescence Detection of Mutant Huntingtin Exon 1 Aggregation in Drosophila melanogaster and Caenorhabditis elegans.

  2017cites this paper
• Interaction of the polyglutamine protein ataxin-3 with Rad23 regulates toxicity in Drosophila models of Spinocerebellar Ataxia Type 3

  2017cites this paper
• Bar-coding neurodegeneration: identifying subcellular effects of human neurodegenerative disease proteins using Drosophila leg neurons

  2017influential citation
• Polyglutamine expansion diseases: More than simple repeats.

  2017cites this paper
• Using Drosophila for Studies of Intermediate Filaments.

  2016cites this paper
• COLLECTION : TRANSLATIONAL IMPACT OF DROSOPHILA Assessing a peptidylic inhibitor-based therapeutic approach that simultaneously suppresses polyglutamine RNA-and protein-mediated toxicities in patient cells and Drosophila

  2016cites this paper
• Caracterizaçāo das citocinas na doença de Machado Joseph

  2016cites this paper
• A peptidylic inhibitor-based therapeutic approach that simultaneously suppresses RNA-and protein-mediated toxicities in polyglutamine diseases

  2016cites this paper
• Antisense Oligonucleotide Tool in Therapy for Polyglutamine Neurodegenerative Disorders

  2016influential citation
• Dysregulation of Ubiquitin-Proteasome System in Neurodegenerative Diseases

  2016influential citation
• RAN translation at CGG repeats induces ubiquitin proteasome system impairment in models of fragile X-associated tremor ataxia syndrome.

  2015cites this paper
• Genetic polymorphisms in ataxin-3 and liver cirrhosis risk related to aflatoxin B1

  2015cites this paper
• Studying polyglutamine diseases in Drosophila.

  2015cites this paper
• Identification of novel genes interacting with DVAP, the causative gene of ALS8 in humans

  2015cites this paper
• Drosophila as an In Vivo Model for Human Neurodegenerative Disease

  2015influential citation
• The Role of the Mammalian DNA End-processing Enzyme Polynucleotide Kinase 3’-Phosphatase in Spinocerebellar Ataxia Type 3 Pathogenesis

  2015cites this paper
• Proteasomal Degradation of Soluble, Misfolded Proteins: Throwing out the Bath Water, but Where's the Baby?

  2015cites this paper
• The deubiquitinase ataxin-3 requires Rad23 and DnaJ-1 for its neuroprotective role in Drosophila melanogaster.

  2015cites this paper
• Inhibition of Transglutaminase Exacerbates Polyglutamine-Induced Neurotoxicity by Increasing the Aggregation of Mutant Ataxin-3 in an SCA3 Drosophila Model

  2015cites this paper
• Toward therapeutic targets for SCA3: Insight into the role of Machado-Joseph disease protein ataxin-3 in misfolded proteins clearance.

  2015cites this paper
• The amazing ubiquitin-proteasome system: structural components and implication in aging.

  2015cites this paper
• Deubiquitinases and the new therapeutic opportunities offered to cancer

  2015cites this paper
• Quantification of Ataxin-3 and Ataxin-7 aggregates formed in vivo in Drosophila reveals a threshold of aggregated polyglutamine proteins associated with cellular toxicity.

  2015cites this paper
• Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease.

  2015cites this paper
• DnaJ-1 and karyopherin α3 suppress degeneration in a new Drosophila model of Spinocerebellar Ataxia Type 6.

  2015influential citation
• Protein Quality Control in Brain Aging: Lessons from Protein Misfolding Disorders in Drosophila

  2015cites this paper
• Allele-selective suppression of mutant genes in polyglutamine diseases

  2015cites this paper